fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Boston Children's Hospital · NCT04439552
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 8–35 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- October 4, 2021
- Record last updated
- December 19, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Evaluation of neuroplasticity of pain pathways and corneal afferent nerve regeneration following corneal crosslinking (CXL) in keratoconus patients using fMRI and corneal In Vivo Confocal Microscopy (IVCM).
Conditions: Pain, Postoperative; Pain, Chronic; Pain, Acute; Surgical Injury; Surgical Wound; Cornea Injury; Cornea; Keratoconus
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
CXL Group
- Age 8-35 years
- Clinical diagnosis of keratoconus and seeking CXL treatment
- English speaking ability sufficient to comprehend consent with parental assistance
- MRI compatible
- Ability to lie still for an MRI session (60 minutes)
Control Group
- Age 8-35 years
- No diagnosis of keratoconus
- English speaking ability sufficient to comprehend consent with parental assistance
- MRI compatible
- Ability to lie still for an MRI session (60 minutes)
Exclusion Criteria (Both Groups):
- Claustrophobic
- Weight > 285 lbs (weight limit of the MRI table)
- Significant medical history, including:
Current DSM-IV-TR axis I psychiatric disorders. Chronic pain Significant head injury Seizures Brain tumor Cerebrovascular accident Neurological disease aside from migraine HIV-AIDs Prescription medication strongly implicated in causing dry eyes
- Magnetic implants or metal-containing tattoos on their chest or above
- Pregnancy
- History of contact lens wear
- Any allergic response to a numbing eyedrop in the past
Recruiting US locations
Boston Children's Hospital
Boston, MA 02115
Site contact: Nicholas J Pondelis, BA · 617-919-1895 · nicholas.pondelis@childrens.harvard.edu
Study contacts (from the official record)
- Eric A Moulton, OD PhD · 617-919-6827 · eric.moulton@childrens.harvard.edu
- Nicholas J Pondelis, BA · 617-919-1895 · nicholas.pondelis@childrens.harvard.edu
Similar studies in Massachusetts
All pain studies in Massachusetts →- RecruitingHealthy volunteersOvernight stay mentioned
The Osteoarthritis Prevention Study
Wake Forest University
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 50+ · Women only
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Boston, MA + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Burlington, MA + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Eli Lilly and Company
- Location
- New Bedford, MA + 34 other US sites
- Eligibility basics
- Ages 18+